SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-012395
Filing Date
2021-05-17
Accepted
2021-05-17 07:56:58
Documents
40
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20210331_10q.htm 10-Q 436674
2 EXHIBIT 4.1 ex_240206.htm EX-4.1 63236
3 EXHIBIT 31.1 ex_240207.htm EX-31.1 19603
4 EXHIBIT 31.2 ex_240208.htm EX-31.2 14567
5 EXHIBIT 32.1 ex_240209.htm EX-32.1 10493
  Complete submission text file 0001437749-21-012395.txt   2887106

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnpx-20210331.xml EX-101.INS 384905
7 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20210331.xsd EX-101.SCH 33626
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20210331_cal.xml EX-101.CAL 18890
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20210331_def.xml EX-101.DEF 247732
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20210331_lab.xml EX-101.LAB 240003
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20210331_pre.xml EX-101.PRE 262374
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 21927632
SIC: 2834 Pharmaceutical Preparations